Emerging role of biosimilars: Focus on trastuzumab and metastatic human epidermal growth factor receptor 2-positive breast cancer

Overview

cited authors

Sarder, Lyudmila U.; Ahmad, Sarfraz

Publication Date

December 1, 2023

webpage

Web of Science

published in

RESULTS IN CHEMISTRY Journal

Research

keywords

Biosimilars
Breast cancer
Cost-effectiveness
HER2-positive
Trastuzumab
Treatment

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.